Aptiv price target raised to $120 from $115 at Wells Fargo

Wells Fargo analyst Colin Langan raised the firm’s price target on Aptiv to $120 from $115 and keeps an Equal Weight rating on the shares after the company provided bullish 2025 and 2030 margin targets at its Investor Day. The event focused on key growth drivers. Wells is surprised by the aggressive margin targets following the recent challenges.